找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Chemotherapy and Urological Malignancy; A. S. D. Spiers (Professor of Medicine) Book 1982 Springer-Verlag Berlin Heidelberg 1982 Urogenita

[復(fù)制鏈接]
樓主: 退縮
21#
發(fā)表于 2025-3-25 04:47:27 | 只看該作者
Chemotherapy of Cancer of the Prostate,he expected annual incidence is 42000 new cases with 17000 deaths. It has been estimated that 30% of cases are potentially curable when first discovered but this is open to serious question (Klein 1979). Between 1950 and 1970 the reported incidence of prostatic carcinoma rose from 17 to 21 per 10000
22#
發(fā)表于 2025-3-25 09:48:12 | 只看該作者
23#
發(fā)表于 2025-3-25 13:44:20 | 只看該作者
,Urological Oncology — A European View,ontinuing financial support from the National Cancer Institute (NCI) in Bethesda. It has also been aided in the last 5 years by private donations collected by the EORTC foundation and, since 1979, has had official support from the European Community.
24#
發(fā)表于 2025-3-25 15:55:56 | 只看該作者
25#
發(fā)表于 2025-3-25 23:50:27 | 只看該作者
Chemotherapy and Urological Malignancy978-1-4471-1332-4Series ISSN 0177-8994
26#
發(fā)表于 2025-3-26 01:46:23 | 只看該作者
Quick Guide to the Management of Keratoconusontinuing financial support from the National Cancer Institute (NCI) in Bethesda. It has also been aided in the last 5 years by private donations collected by the EORTC foundation and, since 1979, has had official support from the European Community.
27#
發(fā)表于 2025-3-26 04:46:45 | 只看該作者
https://doi.org/10.1007/978-1-4471-1332-4Urogenitalkrebs; Zytostatikum; cancer; carcinoma; chemotherapy; kidney; prostate; tumor
28#
發(fā)表于 2025-3-26 10:50:05 | 只看該作者
29#
發(fā)表于 2025-3-26 15:42:54 | 只看該作者
Dynamic Asset Allocation with Credit Riskence of this tumor is only 0.2/100,000. However, the propensity for adrenal cortical carcinoma to excrete hormones has led to unique groups of drugs which produce significant palliation of bothersome and life-threatening endocrinologically induced symptoms. Cushing’s syndrome, virilization, feminiza
30#
發(fā)表于 2025-3-26 20:20:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新兴县| 社旗县| 盐边县| 阿克陶县| 平陆县| 府谷县| 淮南市| 若羌县| 海兴县| 沾益县| 南康市| 新绛县| 噶尔县| 宿迁市| 安塞县| 永定县| 吉木萨尔县| 射洪县| 固安县| 许昌县| 台湾省| 团风县| 松桃| 宁阳县| 巧家县| 桐乡市| 梅州市| 连南| 尚志市| 建水县| 莫力| 容城县| 涟水县| 南溪县| 加查县| 左云县| 科技| 平山县| 抚顺县| 无锡市| 固始县|